In-Depth Analysis Of The North American Active Pharmaceutical Ingredients (API) Market
New report provides detailed analysis of the Chemicals market
Published on February 06, 2010 Comments (Be the first)
by Press Office
(Companiesandmarkets.com and OfficialWire)
LONDON, ENGLAND
This new report "North American Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020" provides in-depth analysis of the North American active pharmaceutical ingredients (API) market and presents revenue forecasts up to 2020 for the United States and Canada. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole North American market is also covered in the report.
Economic Crisis Slows the Revenue Growth of the North American API Market
The current global economic crisis has negatively affected the North American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings of the healthcare expenditure, there is a shift away from the high-priced innovative drugs in the United States and Canada. This has resulted in a significant slowdown in the revenue growth of the North American API market. In 2009, the North American API market is set grow at a rate of around 2%.
Biotech APIs Set to Drive the Overall Growth of the API Market in North America
The biotech API market in North America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for the biological drugs is boosting the demand for the biotech API in the market place. Also, the technological advancement in the pharmaceutical industry is paving way for newer biotechnology drugs. The pharmaceutical industry is also optimistic about the approval of biogeneric drugs which is expected to create further growth in the development of the biotech API market. This will boost the growth of the biotech API market making it to grow at a rate significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 13% from 2008 to 2020. Generic APIs Get a Boost Due to the Cost-Containment Measures in North America
The generic APIs in the North American API market is witnessing increased growth as a result of the slew of cost-containment measures followed by the governments of the United States and Canada. Primarily, the API market in North America has been driven by innovative sector. However, the expensive nature of the drugs, that increases the overall healthcare expenditure of the country, has compelled the Government to implement steps that will step up the growth of the generic sector. The low-priced generic drugs enable a cost reduction of around 30-40% due to which it has gained increased acceptance in the wake of recession. As a result of such aggressive measures to boost the growth of the generic drugs in the North American region, the under-developed generic API market is expected to get a stronger boost in its growth. Generic APIs are expected to grow at a CAGR of around 8% from 2008 to 2020 that is significantly higher than the innovative sector which is set to grow at a modest rate of 2% for the same time period in North America.
Canada Poised to Increase its Revenue Share in the North American API Market
The Canadian API market, which held a revenue share of around 6% in 2008, is bound to increase its share to 7% in 2015. The Canadian API market is characterized by an emerging biotech API product segment which is growing fastest in the North American market. Adding to this, Canada is expected to have a quick recovery from the recession compared to the United States which will keep the country’s API market growing at a higher rate. This higher growth is set to enable the Canadian API market to gain revenue share during the period 2008-2020.
North America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020
Summary
This report will provide an analysis of the Active Pharmaceutical Ingredients market in key countries of North America region. The report will provide in-depth analysis of volume and revenue of the Active Pharmaceutical Ingredients market in North America. The pricing trend of the market will also be analyzed in the report. This report also contains detailed market share analysis of top companies operating in all the major regions.
Scope
- Detailed analysis of volumes and revenues of Active Pharmaceutical Ingredients in all the major countries in North America and forecasts till 2020 - Detailed analysis of the end applications of Active Pharmaceutical Ingredients in all the major countries in North America - Detailed analysis and forecasts of Active Pharmaceutical Ingredients prices in all the major countries in North America - Thorough analysis of key drivers of growth of the Active Pharmaceutical Ingredients market in all the major countries in North America - Detailed analysis of the market share of the major Active Pharmaceutical Ingredients producing companies in the major countries in North America
Reasons to buy
- The report acts as a guide to the industry professionals and beginners to gain significant understanding about the Active Pharmaceutical Ingredients market in North America - To identify the most attractive geographies, markets and sectors to increase business - Develop custom strategies based on the current and forecasted trends in the volumes and revenues of Active Pharmaceutical Ingredients market - Benchmark different geographies by the historic and forecasted growth of volumes and revenues of Active Pharmaceutical Ingredients and the drivers, restraints and challenges unique to each of the major countries in North America - Benchmark your company with the top Active Pharmaceutical Ingredient producers with comprehensive information of the market share of top companies operating in each of the major regions
The Affordable Business Wire of Choice For PR Professionals ™
OfficialWire was founded April 24, 2001 | Designed by gregPR ™ Journalist Registration | Meet our Media Partners.
To advertise on OfficialWire simply register and upload your ad using our automated ad server.
This service is provided subject to OfficialWire's standard Terms and Conditions. Please read our Privacy Policy. OfficialWire®, Give Good PR ™, Be The News...™ & The Affordable Business Wire of Choice For PR Professionals ™ are trademarks owned by Greg Smith | OfficialWire, ISSN: 1550-1531, is continuously published by Greg Smith Compare OfficialWire to other press release distribution services | Testimonials
—
